Insider · CIK 0001788524
Rahsaan Thompson
Files at ZVRA (ZEVRA THERAPEUTICS, INC.). First filing Jun 30, 2025, latest Aug 17, 2026.
In brief
Rahsaan Thompson files SEC Form 4 as officer at ZVRA (ZEVRA THERAPEUTICS, INC.). Since Jun 30, 2025, Rahsaan Thompson has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.2M, the latest filed on Aug 17, 2026.
A track record needs three past buys with six months of prices behind them; Rahsaan Thompson has 0, so none is measured yet.
The newest scored trade: sold $475k of ZVRA on Aug 14, 2026, filed Aug 17, 2026, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $969k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZVRA: ZEVRA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ZEVRA THERAPEUTICS, INC. | $475k 42,666 shares | -53% | +57% from low-23% from high | |
| 7Weak | ZEVRA THERAPEUTICS, INC. | $438k 34,557 shares | -30% | +75% from low-7% from high | |
| 0Weak | ZEVRA THERAPEUTICS, INC. | $20k 1,794 shares | -4% | +49% from low-16% from high | |
| 1Weak | ZEVRA THERAPEUTICS, INC. | $36k 4,080 shares | -8% | +37% from low-30% from high | |
| 17Weak | ZEVRA THERAPEUTICS, INC. | $221k 24,000 shares | -36% | +41% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 14, 2026 | ZVRA ZEVRA THERAPEUTICS INC | 42,666 0.07% of outstanding | $477k | Aug 14, 2026 | $438k |
| May 11, 2026 | ZVRA Zevra Therapeutics, Inc. | 36,351 0.06% of outstanding | $405k | May 11, 2026 | none |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS INC | 4,080 0.01% of outstanding | $36k | Jan 30, 2026 | none |
| Jun 26, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | 24,000 0.04% of outstanding | $224k | Jun 26, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -42,666 | $11.13 | $475k | 37,569 | Aug 17, 2026 |
| Jun 21, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +66,667 | - | - | 114,792 | Jun 23, 2026 |
| Jun 22, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -34,557 | $12.68 | $438k | 80,235 | Jun 23, 2026 |
| Jun 21, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -66,667 | $0.00 | $0 | 66,667 | Jun 23, 2026 |
| May 11, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,794 | $11.30 | $20k | 48,125 | May 13, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,333 | - | - | 53,999 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -4,080 | $8.83 | $36k | 49,919 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitderivative10b5-1 | +37,500 | $0.00 | $0 | 37,500 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +75,000 | $0.00 | $0 | 75,000 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -11,333 | $0.00 | $0 | 22,667 | Feb 2, 2026 |
| Jun 26, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -24,000 | $9.21 | $221k | 42,666 | Jun 30, 2025 |
| Jun 21, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock | +66,666 | - | - | 66,666 | Jun 24, 2025 |
| Jun 21, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative | -66,666 | $0.00 | $0 | 133,334 | Jun 24, 2025 |
Questions about Rahsaan Thompson
Answered from the filings on this page, as of the latest one.
Is Rahsaan Thompson buying or selling?
In the last 12 months Rahsaan Thompson reported 0 open-market buys worth $0 and 4 open-market sells worth $969k on SEC Form 4; the latest was sold $475k of ZVRA on Aug 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Rahsaan Thompson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rahsaan Thompson has 0.
Where does Rahsaan Thompson file Form 4?
Rahsaan Thompson has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.) as Chief Legal & Compliance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.